Response to the Letter regarding the EBIOM-D-23-04056: "CPAP may promote an endothelial inflammatory milieu in sleep apnoea after coronary revascularization".

Competing Interests: Declaration of interests Y.P. received institutional grants from ResMed Foundation and ResMed Ltd. S.R. received consulting fees from Apnimed Inc., and consulting fees and support for travel from Eli Lilly Inc. S.R. is an unpaid Board member for the National Sleep Foundation and Alliance for Sleep Apnea Partners. D.J.G. received consulting fees from Powell–Mansfield, Inc., and fees for participation on Scientific Advisory Board from Signifier Medical Technologies and Wesper, Inc., and fees for participation on Data Monitoring Committee from Apnimed, Inc. All other authors declare no competing interests.